http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI1001528-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1be7c18863e9e38f6ca9d67153b5d53 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-28 |
| filingDate | 2010-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7edbb3c554bf81e050c9d2a837515031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ac0b1f103a98e0eadbf6b8df62ce983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bacbc2ca7ff08aa59ed36230f7608f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3683c7bcb131862f52d63c4c3288984 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ae83245fa8d7b45ad1a99acea925360 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_383c500d181f32db8e8ab602f6ed8398 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36c37d0eae8dae8adc37680a398c6420 |
| publicationDate | 2011-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI1001528-A2 |
| titleOfInvention | antiviral pharmaceutical composition for controlled release and its preparation process |
| abstract | Antiviral pharmaceutical composition for controlled release and its preparation process The present invention relates to a buccal mucoadhesive pharmaceutical composition for controlled release and the process for preparing such a composition. The composition comprises plant extract as an active ingredient, preferably standardized extract of Achyrocline satureioides, which has antiviral action (HSV-1 and HSV-2). The controlled release composition comprises at least one active ingredient and a system of polymers, which delay the release of the active ingredient in the oral cavity, as well as providing mucoadhesive properties, in addition to optionally including other pharmaceutically acceptable excipients. The composition provides therapeutically effective levels of the active ingredient during the period of time in which the composition maintains its mucoadhesive properties. |
| priorityDate | 2010-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.